跳至主要内容
临床试验/NCT01174719
NCT01174719已完成4 期

Phase 4 Study Comparing Albumin 5%, Hydroxyethylstrach 130/0.4 (6%) and Ringer Lactate for Volume Replacement During Cardiac Surgery

Medical University of Vienna1 个研究点 分布在 1 个国家目标入组 240 人开始时间: 2006年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
240
试验地点
1
主要终点
chest tube drainage

研究概览

简要总结

The aim of the study is to compare three different regimens for volume replacement during cardiac surgery, e.g. Albumin 5%, Hydroxyethylstarch 130/0.4 (HES) and Ringer-Lactate (RL).

Main Outcome parameters: chest tube drainage and coagulation parameters. The investigators hypothesis is that HES is as safe as Albumin, however less expensive. Whether RL is an even less expensive and as safe alternative has to be shown.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
20 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Valve replacement
  • Coronary bypass surgery

排除标准

  • Severe left ventricular dysfunction
  • Coagulation disorders

研究组 & 干预措施

Ringer lactate

Active Comparator

干预措施: volume replacement (Drug)

Humanalbumin

Active Comparator

干预措施: Humanalbumin 5% (Drug)

Hydroxyethylstarch

Active Comparator

干预措施: volume replacement (Drug)

结局指标

主要结局

chest tube drainage

时间窗: 24 hours

次要结局

  • Hemoglobin concentration(24 hours after surgery)
  • platelet count(24 hrs after surgery)
  • Hematocrit value(24 hours after surgery)
  • activated clotting time(30 minutes after arrival ICU)
  • Modified thromboelastometry coagulation analysis (ROTEM, Pentapharm, Munich, Germany)(24 hrs after surgery)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Eva M. Base

Associate Professor

Medical University of Vienna

研究点 (1)

Loading locations...

相似试验